Johanna Contreras
Overview
    Explore the profile of Johanna Contreras including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              43
            
            
              Citations
              378
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Vinayak M, Serrao G, Rao A, Contreras J, Sharma S, Kini A, et al.
  
  
    JACC Cardiovasc Interv
    . 2025 Mar;
    
    PMID: 40047748
  
  
          No abstract available.
      
2.
        
    
    Maenza J, Chopra L, Mannina C, Vaish E, Prakash Y, Contreras J, et al.
  
  
    Cardiovasc Revasc Med
    . 2024 Nov;
    
    PMID: 39550305
  
  
          No abstract available.
      
3.
        
    
    Javed N, Jadhav P, Chilimuri S, Contreras J, Tamis-Holland J, Bella J
  
  
    Am Heart J Plus
    . 2024 Oct;
          46:100462.
    
    PMID: 39351148
  
  
          Background: Current knowledge about non-acute myocardial infarction-associated cardiogenic shock (nAMI-CS) by ethnicity is limited. This study compares clinical features and outcomes of nAMI-CS in Hispanic versus non-Hispanic patients in the...
      
4.
        
    
    Contreras J, Tinuoye E, Folch A, Aguilar J, Free K, Ilonze O, et al.
  
  
    Heart Fail Clin
    . 2024 Aug;
          20(4):353-361.
    
    PMID: 39216921
  
  
          Minoritized racial and ethnic groups have the highest incidence, prevalence, and hospitalization rate for heart failure. Despite improvement in medical therapies and overall survival, the morbidity and mortality of these...
      
5.
        
    
    Moras E, Shrivastav R, Gandhi K, Bandyopadhyay D, Isath A, Goel A, et al.
  
  
    J Clin Med
    . 2024 Aug;
          13(15).
    
    PMID: 39124821
  
  
           Clinical trials demonstrating improved cardiovascular outcomes with SGLT2 inhibitors have often had limited representation from Black and Hispanic populations. While the mechanisms of action are not well known, ethnicity- or...
      
6.
        
    
    Tamirisa K, Ogunniyi M, Chen M, Contreras J, Tong A, Kadiyala M, et al.
  
  
    J Am Coll Cardiol
    . 2024 Jul;
          84(2):219-222.
    
    PMID: 38960517
  
  
          No abstract available.
      
7.
        
    
    Saldarriaga C, Garcia-Arango M, Valentina Lopez L, Contreras J
  
  
    J Card Fail
    . 2024 Jun;
          30(8):991-993.
    
    PMID: 38823433
  
  
          No abstract available.
      
8.
        
    
    Sherif A, Gilvaz V, Abraham S, Saji A, Mathew D, Isath A, et al.
  
  
    ESC Heart Fail
    . 2024 Mar;
          11(4):1900-1910.
    
    PMID: 38472730
  
  
          Aims: We aimed to analyse the characteristics and in-hospital outcomes of patients hospitalized for heart failure (HF) with co-morbid systemic sclerosis (SSc) and compare them to those without SSc, using...
      
9.
        
    
    Contreras J, Nussbaum J, Cangialosi P, Thapi S, Radakrishnan A, Hall J, et al.
  
  
    J Clin Med
    . 2024 Jan;
          13(1).
    
    PMID: 38202292
  
  
          Minoritized racial and ethnic groups suffer disproportionately from the incidence and morbidity of pulmonary hypertension (PH), as well as its associated cardiovascular, pulmonary, and systemic conditions. These disparities are largely...
      
10.
        
    
    Bhardwaj A, Contreras J
  
  
    JACC Heart Fail
    . 2023 Dec;
          11(12):1705-1707.
    
    PMID: 38056972
  
  
          No abstract available.